Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer-Reference-Cited by-同舟云学术

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

Published:2018-03-28 Issue:8 Volume:118 Page:1056-1061
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Muñoz Martín Andrés J.,Ortega Israel,Font Carme,Pachón Vanesa,Castellón Victoria,Martínez-Marín Virginia,Salgado Mercedes,Martínez Eva,Calzas Julia,Rupérez Ana,Souto Juan C.,Martín Miguel,Salas Eduardo,Soria Jose M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0027-8.pdf

Reference33 articles.

1. Blom, J. W., Doggen, C. J. M., Osanto, S. & Rosendaal, F. R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293, 715–722, (2005).

2. Khorana, A. A., Dalal, M., Lin, J. & Connolly, G. C. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer 119, 648–655, (2013).

3. Noble, S. & Pasi, J. Epidemiology and pathophysiology of cancer-associated thrombosis. Br. J. Cancer 102, S2–S9, (2010).

4. Lyman, G. H. et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society Of Clinical Oncology Clinical Practice Guideline Update 2014. J. Clin. Oncol. 33, 654–656, (2015).

5. Muñoz Martín, A. J., Font Puig, C., Navarro Martín, L. M., Borrega García, P. & Martín Jiménez, M. Clinical guide SEOM on venous thromboembolism in cancer patients. Clinical Transl. Oncol. 16, 1079–1090, (2014).

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation of the Khorana score for the prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis;International Journal of Nursing Studies;2024-11

2. Preventative and curative treatment of venous thromboembolic disease in cancer patients;La Presse Médicale;2024-09

3. Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With Chemotherapy;Clinical Genitourinary Cancer;2024-06

4. Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis;Thrombosis and Haemostasis;2024-05-20

5. Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma;Journal of Thrombosis and Thrombolysis;2024-04-27